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Abstract
Different from the standard treatment discovery framework which is used for finding single 
treatments for a homogenous group of patients, personalized medicine involves finding therapies 
that are tailored to each individual in a heterogeneous group. In this paper, we propose a new 
semiparametric additive single-index model for estimating individualized treatment strategy. The 
model assumes a flexible and nonparametric link function for the interaction between treatment 
and predictive covariates. We estimate the rule via monotone B-splines and establish the 
asymptotic properties of the estimators. Both simulations and an real data application demonstrate 
that the proposed method has a competitive performance.
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1. Introduction
In modern clinical researches, the goal to achieve better outcomes as well as lower cost and 
burden for individual patients has generated tremendous interest in personalized medicine. 
Individualized treatment rules (ITRs) operationalize personalized medicine as a decision 
function from patient’s individual biomarkers to a recommended treatment and the optimal 
ITRs should be the one which maximizes clinical benefit if implemented. Specifically, if we 
AMS 2000 subject classifications: Primary 62G05; secondary 62G99.
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use A to denote treatment assignment taking values of −1 and 1, X to denote all biomarker 
and prognostic information associated with each patient and let Y be the clinical outcome of 
interest (assuming large values are desirable), then an individualized treatment rule (ITR), 
denoted by d(x), takes a given value x of X and provides a treatment choice from {−1, 1}. 
Furthermore, let Pd denote the distribution of (X, A, Y ) and expectation with respect to this 
distribution by Ed, where the individualized treatment rule d(x) is used to assign treatments. 
Define the value function as V (d) = Ed(Y ). Then an optimal ITR, d0, is a rule that has the 
maximal value, i.e., d0 is the maximizer of V (d) over decision rules d.
There has been growing interest in developing valid inference methods for estimating the 
optimal ITRs, d0, using clinical trial data. With trial data, it holds V (d) = E[Y I(A = 
d(X))/π(A|X)] [15], where π(a|X) is the known randomization probability of A = a given X, 
so it is easy to see d0(x) = sign{E[Y|A = 1,X = x] – E[Y|A = −1,X = x]}, where sign(·) 
function is defined as sign(x) = 1 when x > 0, sign(x) = −1 when x < 0. Therefore, most of 
the existing methods tend to model E[Y |A = a,X = x] including the interactions between the 
treatment and the covariates either parametrically or nonparametrically. Such literature 
include likelihood-based approach [19, 18, 20], parametric Q-learning in [1], and machine 
learning based methods [25]. Alternatively, one can parametrically model E[Y|A = a,X = x] 
– E[Y|A = d0(X),X = x] which is called A-learning as discussed in [14] and [16]. Recently, 
directly maximizing V (d) has been proposed using support vector machine in [26] or via 
robust parametric models in Zhang et al. [24]. However, all parametric methods potentially 
suffer from model misspecification especially when X is not low-dimensional and the 
optimal ITRs depends on high-order interactions among X’s. On the other hand, although 
the nonparametric methods such as machine-learning methods are flexible, the resulting 
rules are complicated so may not be interpretable in practice. The latter often comes with no 
rigorous inference procedures as in the parametric methods.
In this paper, we propose a semiparametric single-index model to estimate the optimal ITRs. 
Our model retains a flexible and nonparametric formulation of the treatment-covariate 
interactions but also yields a simple decision rule which only depends on a linear 
combination of X. Specifically, our proposal assumes the following model between Y and 
(X,A):
(1)
where X is a p-dimensional covariate vector and may contain 1 as the intercept, βTX is a 
single index and both μ and ψ are unknown functions. Moreover, ψ is a monotone 
increasing function with ψ(0) = 0. The proposed model has the following advantages in 
developing individualized treatment strategy. First, it provides a more flexible interaction 
between the covariates and the treatment as compared to the traditional parametric models, 
in which we allow a fully nonparametric baseline function of the covariates X, μ(X), and a 
close-to nonparametric interaction between the treatment A and the covariates X. Second, 
we can easily derive the best treatment strategy as d0 : X – → sign(ψ(βTX)). Since ψ is 
increasing, the resulting rule is practically interpretable. Moreover, if ψ(0) = 0, the above 
treatment strategy d0 can be simplified as a simple rule:
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That is, only the sign of a risk score βTX needs to be evaluated for each patient. As a 
separate note, single index models have been studied extensively in literature with a number 
of inference methods developed, including the average derivative method [5], the sliced 
inverse regression [12, 3, 11], the iterative average derivative method [6] and other related 
methods [23]. Estimating both the single index and the link function at the same time has 
also been studied in [9, 8, 4]. However, none of these works have considered the single index 
model for estimating the optimal ITRs, especially that our model (1) assumes the main effect 
of X, μ(X), to be fully nonparametric.
The rest of the paper is organized as follows. In Section 2, we provide a full inference 
procedure for the proposed semiparametric single index model. Extensive simulation studies 
are presented in Section 3 and a real data analysis is presented in Section 4, followed by a 
discussion section.
2. Inference Procedure
Note that model (1) remains the same if we replace ψ(x) by ψ(rx) for any r > 0. Therefore, 
for identifiability, we further require ||β|| = 1 where || · ||is the Euclidean ℓ2-norm in Rp. 
Assume that data are obtained from a randomized trial with i.i.d observations (Yi,Xi,Ai), i = 
1, ..., n. The randomization probability P(A = a|X) = π(a|X) is known by the trial design.
To avoid estimating the nonparametric function μ(X) when making inference for β, we first 
observe that,
Therefore, a natural estimate of β is obtained by minimizing the least square, given as
subject to ||β|| = 1. Since ψ is an increasing function, we approximate ψ(x) using monotone 
B-spline basis [2, 10],
Song et al. Page 3
Electron J Stat. Author manuscript; available in PMC 2018 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
where N1(x), ...,NK<sub>n</sub>+M(x) are B-spline basis, Kn is the number of interior knots 
with equal partition in an interval containing βTX and M is B-spline order, i.e., for cubic B-
spline, M = 4. The condition ξ1 ≤ ⋯ ≤ ξK<sub>n</sub>+M assures monoticity of the ψ(·) 
function [10]. Additionally, we impose an upper bound Mn for the summation of absolute 
values of all the B-spline coefficients of ψ(·) for theoretical consideration. Mn is a constant 
depending on n and the rate of Mn is given in Section 3. Thus, the minimization becomes
(1)
Set d = Kn + M. The objective function in (1) is quadratic in ξ and quite nonlinear in β. The 
constraint ||β|| = 1 is nonlinear in the elements of β. The inequality constraint in (1) is linear 
in ξ since it can be expressed as Bξ ≤ 0, where ξ = (ξ1, ⋯ , ξd)T and B is a (d–1) ×d matrix 
with B(i, i) = 1,B(i, i+1) = −1 and the rest of its entries being zero. To facilitate the 
implementation, we now propose an iterative estimation algorithm to solve (1). In particular, 
we iteratively solve β with ξ fixed at their current values, and then solve ξ with β fixed at 
their current values, and repeat them until the convergence criterion is met. The computation 
procedure can be summarized as the following.
Step 1: Get an initial estimator β(̂0). For example, we can set Nj(βTX) = β TX as a 
linear function in (1) and compute the ordinary least squares (OLS) estimator for β. 
Normalize β(0) such that ||β(0)|| = 1. Set ℓ = 0.
Step 2: Given the initial estimates of the index values {Zi = β(̂ℓ)TXi, i = 1, ⋯ , n}, 
minimize over ξ by solving the followng quadratic programming (QP) problem:
(2)
Denote the solution as ξ̂(ℓ).
Step 3: Fix ξ at the current values, minimize
Denote the solution as β(̂ℓ+1). This problem can be solved using the nonlinear least 
squares (NLS) algorithm.
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Step 4: Set ℓ = ℓ + 1. Go to Step 2 and iterate until convergence, i.e. ||β̂(ℓ) − β̂(ℓ−1)|| ≤ ε 
(1 + ||β̂(ℓ−1)||) and ||ξ̂(ℓ) − ξ̂(ℓ−1)|| ≤ ε (1 + ||ξ̂(ℓ−1)||) for a small ε > 0, which takes value 
1e-3 in our numerical studies.
In our numerical examples, we use the MATLAB’s optimization toolbox: the function 
quadprog() for QP in Step 2 and lsqnonlin() for NLS in Step 3. In this paper, we choose 
cubic B-spline for all numerical studies and real data application. Our algorithm usually 
converges in less than 10 iterations.
Given Kn, we choose to place the interior knots at equally-spaced sample quantile of the 
predictor variable, which is βTX in this context. For example, if there are 4 interior knots, 
then they would be respectively at the 20th, 40th, 60th, 80th percentile. The boundary knots 
are naturally chosen as the minimum and maximum values of the predictor variable. During 
the iteration, the estimated single index β could change at each step, therefore the knots also 
change in the iteration. The number of knots Kn can be tuned with cross-validation. In 
general, 5 to 10 knots will be sufficient to have very good results.
3. Asymptotic Results
We establish the asymptotic properties of the estimators (β̂n, ψ̂n), including their consistency 
under certain metric, the convergence rates, and the asymptotic distribution of . 
We need the following conditions.
(C.1) β0 is assumed to be in the unit ball ℬ of Rp and X has a compact support. In 
addition,  is positive definite. and  is kth 
continuously differentiable with bounded derivatives for some k > 3.
(C.2) ψ0 has bounded kth derivative in an open interval containing the support of 
for some k > 3; moreover, .
(C.3)
 is continuously differentiable in β and moreover,
Under these conditions, we first obtain the consistency and convergence rate of (βn̂, ψ̂n).
Theorem 1
Under (C.1)–(C.3), we further assume Kn = C1nγ and Mn = C2nτ for some positive constants 
C1, C2 with γ > 0, τ ≥ 0, and 11γ + 9τ ≤ 1, 2τ ≤ (2k − 5)γ. Let 0 < ν < 1/2, then
Furthermore,
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where Ws,∞ is the Sobolev space consisting of functions with bounded lth derivatives for 
any l ≤ s. Furthermore, the Sobolev norm is defined as ||ψ|| W1,∞[a,b] = maxα≤1 ||
ψ(α)||L∞[a,b].
The asymptotic distribution of β̂n is stated in the following theorem.
Theorem 2
In addition to (C.1)–(C.3), we assume Kn = C1nγ and Mn = C2nτ for some positive constants 
C1, C2 with γ > 1/(4k − 4), τ ≥ 0 and 11γ +9τ ≤ 1, 2τ ≤ (2k − 5)γ. Then 
converges in distribution to a mean-zero normal distribution with covariance 
, where
and
Based on Theorem 2, a consistent estimator for the asymptotic covariance is given by 
 in which Σ̂1 and Σ̂2 are given as follows. Then an estimator for Σ1 is given as
Since
an estimator for Σ2 is given by
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Under Theorem 1, it is clear that both Σ̂1 and Σ̂2 are consistent estimators for Σ1 and Σ2 
respectively when the sample size converges to infinity. Finally, we estimate the optimal 
decision rule as . Under such a rule, for any subject, the reward gain of using the 
optimal rule vs the non-optimal rule is estimated to be .
4. Numerical Studies
In this section, we conduct extensive simulations to investigate the empirical performance of 
our proposed method. We first use three examples (Examples I–III) to compare our method 
with the inverse probability weighted estimator( IPWE), augmented inverse probability 
weighted estimator(AIPWE) in [24] and ordinary least square based on minimizing
Finally, in Example IV, we investigate the performance of our method under model 
misspecification (i.e. when ψ(·) is not monotone).
We consider the model Y = μ(X) + ψ(βTX)A + ε where X is generated uniformly from [−1, 
1]p, A is generated as −1 and 1 with equal probability 0.5 and the noise ε follows a normal 
distribution with mean 0 and standard deviation σ = 0.5. The four examples are:
Example I : p = 2, , ψ(u) = 2u3 − 1, .
Example II : p = 3, , ψ(u) = exp(u) − 1, .
Example III : p = 4, , ψ(u) = u3 − 1, .
Example IV : p = 3, , ψ(u) = cos(2u) + sin(4u), 
.
To evaluate the estimation performance of the single index coefficient, we report its bias and 
the mean squared error MSE(β) = average over replications of ||β̂− β0||2/p. To evaluate the 
estimation performance of the link function, we report its mean squared error MSE(ψ) = 
average over replications of . To evaluate the accuracy of a 
treatment assignment rule sign(βTX), we calculate the percentage of making correct 
decisions (PCD), i.e. . We also study the 
behavior of the value function estimates. Based on the estimated rule, the value function can 
be estimated as , where gi is the estimated rule. We compare the proposed 
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method with [24] in terms of parameter estimates, percentage of making correct decisions 
(PCD) and value function estimates.
From Tables 1–3, we observe that our method shows better results compared with the 
inverse probability weighted estimator (IPWE) and the augmented inverse probability 
weighted estimator (AIPWE) [24] in terms of smaller bias of estimated single index 
coefficient, smaller mean square error of estimated link function. In most cases, the bias of 
estimated single index coefficient of our proposed approach is about ten times smaller than 
the other two approaches. As a result, our method also makes more correct decisions and 
gives estimated value function much closer to its theoretical value. We also note that as 
sample size increases, the mean squared error of the single index coefficient and estimated 
link function for three methods decreases, the PCD increases and the estimated value 
function gets closer to the true value function. However, Table 2 indicates that the ordinary 
least square method performs comparably with our method but gives larger PCD than all the 
other methods when ψ(0) = 0. This is simply because that, ψ′ > 0,
Table 4 indicates that all the methods are much worse under model misspecification. 
However, our method is still better compared to IPWE, AIPWE and the ordinary least square 
method. We also investigate our proposed inferential procedure for the single index 
coefficient β. It shows in Table 5 that, as sample size increases, the empirical standard error 
and the mean estimated standard error are getting closer to each other. For almost all cases, 
the empirical coverage rates are very close to the nominal level, as expected.
5. Data application
To further illustrate the performance of our method, we consider its application to data from 
AIDS Clinical Trials Group Protocol 175 (ACTG175). The complete data contain 2139 HIV-
infected subjects with study subjects randomized to four different treatment groups: 
zidovudine (ZDV) monotherapy, ZDV + didanosine (ddI), ZDV + zalcitabine and ddI 
monotherapy. The CD4 count (cells/mm3 ) at 20±5 weeks post-baseline is chosen as the 
continuous response Y, where large values are desired. Among all subjects, 524 subjects 
received the treatments ZDV + didanosine (ddI) and 522 subjects received the treatment 
ZDV + zalcitabine. For illustration purpose, we consider these two group of patients with the 
goal to find their individualized optimal treatment rules. We use A = 1 to denote treatment 
ZDV + zalcitabine and A = −1 to denote treatment ZDV + didanosine (ddI). Besides the 
treatment indicator, we also include two covariates: age and homosexual activity (in short as 
homo), which are selected as important covariates in [13].
We apply the proposed method to estimate the optimal treatment and perform statistical 
inference for the corresponding parameters. The estimates for the single index coefficients 
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are 0.902, −0.036, and 0.430 respectively and the estimated variance of the single index 
coefficients are 0.2232, 0.0004 and 0.0984, respectively. The optimal treatment rule is 
sign(0.902-0.036×age+0.430×homo). That is, if 0.902-0.036×age+0.430×homo ≥ 0, the 
optimal treatment for this patient is ZDV + zalcitabine, otherwise, the optimal treatment is 
ZDV + didanosine( ddI). In other words, for a patient with homo = 0, the optimal treatment 
A = −1 if age > 25.2 and the optimal treatment A = 1 otherwise; while for a patient with 
homo = 1, the optimal treatment A = −1 if age > 37.2 and the optimal treatment A = 1 
otherwise. We note that the age of study subjects ranges from 12 to 70. According to the 
estimated optimal rule, 565 out of 1046 patients (54.02%) in this subset should be assigned 
to treatment ZDV+didanosine (ddI).
6. Discussion
In this paper, we proposed a novel semiparametric single-index model for individualized 
treatment selection. Our model plays an important role as a compromise between parametric 
models and nonparametric models [24]. The decision rule based on our method is a simple 
linear combination of covariates. We provide statistical inference for this rule. The 
asymptotic properties for the proposed method are established. The proposed method 
demonstrates superior numerical behavior in terms of smaller bias and means square error. 
Based on the estimated rule, our method also provides more precise decisions than existing 
methods and gives more precise value function estimates.
In many clinical studies, the state space is often of very high dimension. To develop optimal 
individualized treatment rules in this case, it will be important to develop simultaneous 
variable selection and treatment rule estimation. Variable selection techniques such as 
penalized regression and variable screening can be nested into our semiparametric single 
index modeling framework as powerful tools to develop optimal individualized treatment 
rules.
In our current procedure, we assume the propensity score π(A|X) is known. In observational 
studies, the propensity scores are often unknown. For such observational data, we can 
estimate π(A|X) via logistic regression and plug-in the estimated propensity score funtion 
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π(A|X) into the optimization equation (1). It is beyond the scope of the current work and is 
an interesting topic for future study.
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Fig 1. 
Estimation performance for link function based on mean of 10 replications of Example 1–4 
when n = 500.
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